Semi-closed-circuit vacuum-assisted mini percutaneous nephrolithotomy in the pediatric population: the initial experience of two tertiary referral centers.


Journal

Minerva urology and nephrology
ISSN: 2724-6442
Titre abrégé: Minerva Urol Nephrol
Pays: Italy
ID NLM: 101777299

Informations de publication

Date de publication:
02 2022
Historique:
pubmed: 6 10 2020
medline: 15 3 2022
entrez: 5 10 2020
Statut: ppublish

Résumé

Percutaneous nephrolithotomy (PCNL) is the gold-standard for complex renal stones treatment in the pediatric population. While the miniaturization of PCNL reduces the risk of bleeding, it can hinder surgical and functional outcomes. The aim of the study was to assess the safety and feasibility of semi-closed-circuit vacuum-assisted Mini-PCNL (vmPCNL) in pediatric patients. From January 2017 to December 2018, we prospectively collected data on consecutive vmPCNLs from two European tertiary referral centers. The procedure was performed with the ClearPetra Eighteen vmPCNLs were performed in 16 renal units of 13 children. The median age was 119 months (IQR: 97-160) and the weight was 29 Kg (IQR: 25-40). The median cumulative stone size was 32 mm (22-46) with 8 (44.4%) cases of staghorn stones. The OT was 128 min (IQR: 99-167). The basketing was unnecessary in 6/18 (33%) cases. Neither intra-operative complications nor blood transfusions occurred. Postoperative fever was observed in 5/18 (27.8%) cases; in one case a double J ureteral stent was placed for concomitant hydronephrosis. The SFR was 81.3% (13/16), rising to 93.8% (15/16) after ancillary procedures. The materials costs of a vmPCNL (734.8 €) were comparable to mini-PCNL using a reusable set (710.7 €). The vmPCNL seems to be sustainable, safe and feasible for kidney stones treatment in the pediatric population.

Sections du résumé

BACKGROUND
Percutaneous nephrolithotomy (PCNL) is the gold-standard for complex renal stones treatment in the pediatric population. While the miniaturization of PCNL reduces the risk of bleeding, it can hinder surgical and functional outcomes. The aim of the study was to assess the safety and feasibility of semi-closed-circuit vacuum-assisted Mini-PCNL (vmPCNL) in pediatric patients.
METHODS
From January 2017 to December 2018, we prospectively collected data on consecutive vmPCNLs from two European tertiary referral centers. The procedure was performed with the ClearPetra
RESULTS
Eighteen vmPCNLs were performed in 16 renal units of 13 children. The median age was 119 months (IQR: 97-160) and the weight was 29 Kg (IQR: 25-40). The median cumulative stone size was 32 mm (22-46) with 8 (44.4%) cases of staghorn stones. The OT was 128 min (IQR: 99-167). The basketing was unnecessary in 6/18 (33%) cases. Neither intra-operative complications nor blood transfusions occurred. Postoperative fever was observed in 5/18 (27.8%) cases; in one case a double J ureteral stent was placed for concomitant hydronephrosis. The SFR was 81.3% (13/16), rising to 93.8% (15/16) after ancillary procedures. The materials costs of a vmPCNL (734.8 €) were comparable to mini-PCNL using a reusable set (710.7 €).
CONCLUSIONS
The vmPCNL seems to be sustainable, safe and feasible for kidney stones treatment in the pediatric population.

Identifiants

pubmed: 33016029
pii: S0393-2249.20.03951-X
doi: 10.23736/S2724-6051.20.03951-X
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

93-101

Auteurs

Andrea Gallioli (A)

Unit of Urology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy - andrea.gallioli@gmail.com.

Alfredo Berrettini (A)

Unit of Pediatric Urology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Gianluca Sampogna (G)

Unit of Urology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Unit of Pediatric Urology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Erika Llorens (E)

Division of Pediatric Urology, Fundaciò Puigvert, Barcelona, Spain.

Yesica Quiróz (Y)

Division of Pediatric Urology, Fundaciò Puigvert, Barcelona, Spain.

Michele Gnech (M)

Unit of Pediatric Urology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Elisa DE Lorenzis (E)

Unit of Urology, Department of Clinical Sciences and Community Health, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Giancarlo Albo (G)

Unit of Urology, Department of Clinical Sciences and Community Health, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Joan Palou (J)

Department of Urology, Fundació Puigvert, Barcelona, Spain.

Gianantonio Manzoni (G)

Unit of Pediatric Urology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Anna Bujons (A)

Division of Pediatric Urology, Fundaciò Puigvert, Barcelona, Spain.

Emanuele Montanari (E)

Unit of Urology, Department of Clinical Sciences and Community Health, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH